Indications and uses
temporarily relieves pain and minor irritation of the mouth and gums due to ▪ canker sores ▪ minor dental procedures ▪ braces ▪ dentures
temporarily relieves pain and minor irritation of the mouth and gums due to ▪ canker sores ▪ minor dental procedures ▪ braces ▪ dentures
snip off tip of tube apply to affected area; carefully coat with a protective layer supervise children using this product adults and children 2 years and over: use up to 4 times daily or as directed by a doctor children under 2 years: do not use
Benzocaine 20%
Oral anesthetic/analgesic
temporarily relieves pain and minor irritation of the mouth and gums due to ▪ canker sores ▪ minor dental procedures ▪ braces ▪ dentures
Methemoglobinemia warning: Use of this product may cause methemoglobinemia, a serious condition that must be treated promptly because it reduces the amount of oxygen carried in blood. This can occur even if you have used this product before. Stop use and seek immediate medical attention if you or a child in your care develops: ▪ pale, gray, or blue colored skin (cyanosis) ▪ headache ▪ rapid heart rate ▪ shortness of breath ▪ dizziness or lightheadedness ▪ fatigue or lack of energy
Allergy alert: do not use this product if you have a history of allergy to local anesthetics such as procaine, butacaine, benzocaine or other “caine” anesthetics
If more than used for pain is accidentally swallowed, get medical help or contact a Poison Control Center right away.
aloe barbadensis leaf extract, butylated hydroxytoluene, carbomer hompolymer, cetylpyridinium chloride, chamomilla recutita (matricaria) flower extract, cocos nucifera (coconut) oil, commiphora myrrha resin, dimethicone, echinacea purpurea extract, flavor, glyceryl stearate, menthol, mineral oil, silica dimethicone silylate, vitamin E, white petrolatum
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 244323 | benzocaine 20 % Oral Ointment | PSN | 4 |
| 1489070 | Red Cross Canker Sore 20 % Oral Ointment | PSN | 4 |
| 1489070 | benzocaine 0.2 MG/MG Oral Ointment [Red Cross Canker Sore] | SBD | 4 |
| 244323 | benzocaine 0.2 MG/MG Oral Ointment | SCD | 4 |
| 244323 | benzocaine 20 % Oral Ointment | SY | 4 |
| 1489070 | Red Cross Canker Sore 0.2 MG/MG Oral Ointment | SY | 4 |
| 1489070 | Red Cross Canker Sore 20 % Oral Ointment | SY | 4 |
| Class | Version | Type | Effective |
|---|---|---|---|
| BENZOCAINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 10742-8915-1 | 2023-02-07 | C162847 | 48780-1 | f386c649-faaa-0266-e053-dadaa90a7c1a | Drug Facts - Red Cross Canker Sore |
| 10742-8915-1 | 2023-01-30 | C162847 | 48780-1 | f386c649-faaa-0266-e053-dadaa90a7c1a | Drug Facts - Red Cross Canker Sore |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 10742-8915-1 | Red Cross Canker Sore | 7 g in 1 TUBE | OINTMENT | 7 | 4 | |
| 10742-8915-1 | Red Cross Canker Sore | 1 in 1 BLISTER PACK | OINTMENT | 1 | 4 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 10742-8915 | RED CROSS CANKER SORE (BENZOCAINE) OINTMENT [THE MENTHOLATUM COMPANY] | 4 | Current NDC, Legacy NDC, 2 package rows | 20241219_54cfff96-6665-4b36-a15d-10bf6cf3a1f9.zip |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 10742-8915 | 10742-8915-1 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Red Cross Canker Sore | BENZOCAINE | The Mentholatum Company | 54cfff96-6665-4b36-a15d-10bf6cf3a1f9 | 2024-12-17 | Warnings | 10742-8915-1 10742-8915 10742891501 2979ed4e-4ce2-bd7d-e063-6294a90acb9f 54cfff96-6665-4b36-a15d-10bf6cf3a1f9 |
Adverse event summaries are temporarily unavailable. Other product information remains available.